Medical Properties Trust Inc (NYSE:MPW) shares traded unchanged at $4.61 on Wall Street last session.
MPW stock price is now -13.69% away from the 50-day moving average and -6.20% away from the 200-day moving average. The market capitalization of the company currently stands at $2.77B.
With the price target enhanced from $5 to $9, Exane BNP Paribas Upgraded its rating from Neutral to Outperform for Medical Properties Trust Inc (NYSE: MPW). On September 13, 2024, Colliers Securities Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $6.50, while ‘Exane BNP Paribas’ rates the stock as ‘Neutral’
In other news, Stewart Michael G, Director sold 29,000 shares of the company’s stock on May 05 ’25. The stock was sold for $150,800 at an average price of $5.20. Upon completion of the transaction, the Director now directly owns 216,100 shares in the company, valued at $1.0 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 05 ’25, Director Stewart Michael G bought 29,000 shares of the business’s stock. A total of $150,800 was incurred on buying the stock at an average price of $5.20. A total of 17.90% of the company’s stock is owned by insiders.
During the past 12 months, Medical Properties Trust Inc has had a low of $3.51 and a high of $6.55.
The net profit margin was -174.47% and return on equity was -28.86% for MPW. The company reported revenue of $223.8 million for the quarter, compared to $271.32 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -17.51 percent.
